Dr. Ram Yogendra And Dr. Bruce K. Patterson Bring Covid Longhaulers Syndrome Relief.
Bruce K. Patterson, M.D. is the CEO & Founder of IncellDx and www.covidlonghaulers.com
Bruce K. Patterson, MD is a leading researcher on the effects of viral pathogens on the human immune system. His pioneering technologies and findings have contributed to advances in detection, prognosis and treatment of patients infected with HIV, HPV and cervical cancer, COVID-19 and other diseases.
Using PCR-driven in situ hybridization and flow cytometry to detect viral DNA and RNA within infected cells, Dr. Patterson and colleagues demonstrated that HIV entered and multiplied in the host cells in a stealthy fashion that eluded discovery. This groundbreaking work was published in the peer reviewed journal Science. He also developed a new method to investigate the effect of antiretroviral therapy within the infected host cell and published this discovery in the peer reviewed journal Lancet. Dr. Patterson continues his work on HIV-1 pathogenesis and reservoirs at Stanford University School of Medicine, where he previously served as Medical Director of Diagnostic Virology at Stanford University Hospitals and Clinics, director of clinical virology, and co-director of the AIDS Research Center.
Dr. Patterson received his undergraduate degree in microbiology from the University of Michigan and his MD from Northwestern, where he later served as Chief Resident of Pathology at Northwestern Memorial Hospital. He has authored more than 150 manuscripts and book chapters.
Dr. Patterson serves as CEO of IncellDx, where he is developing a new precision medicine paradigm for predicting, identifying and treating long COVID-19 and other viral pathogens that impair the immune system’s ability to function effectively.
Dr. Ram Yogendra is a board-certified anesthesiologist with a background in public health and exercise physiology. He received his undergraduate degree in biology (B.A.) at Rollins College in Winter Park, Florida and his Master of Public Health (M.P.H.) in Tropical and Communicable Diseases from the University of South Florida, Tampa, Florida. He went onto receive his medical degree (M.D.) from St. George’s University and complete his residency in anesthesiology at the State University of New York Downstate, Brooklyn, New York. Prior to medical school, Dr. Yogendra worked as an Infection Control Practitioner at Florida Hospital (now Advent Health), Orlando, Florida and then in the HIV/AIDS Division of the Pinellas County Department of Health, St. Petersburg, Florida where he was part of the Jail Linkage Project, a collaboration between the DOH and GlaxoSmithKline, to conduct risk assessments of inmates to determine those at high risk of infection and in need of HIV/STD/TB/Hepatitis testing, treatment, and follow-up services.
Twitter: @yodoctoryo and @brucep13